Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Cystic Fibrosis Foundation

CF Foundation Invests Up to $15 million in ReCode Therapeutics to Develop a Gene Editing Therapy
From Cystic Fibrosis Foundation
Via Business Wire
Cystic Fibrosis Foundation Funds Up to $15 Million to Prime Medicine to Pursue Gene Editing in CF
From Cystic Fibrosis Foundation
Via Business Wire
CF Foundation Invests Up to $9 Million in Arcturus Therapeutics to Develop a Messenger RNA Therapy
From Cystic Fibrosis Foundation
Via Business Wire
Cystic Fibrosis Foundation Announces New Members of Board of Trustees
From Cystic Fibrosis Foundation
Via Business Wire
Cystic Fibrosis Foundation Awards 2023 Impact Grants
From Cystic Fibrosis Foundation
Via Business Wire
Cystic Fibrosis Foundation Announces Yvonne Massenburg as Next Chief People Officer
From Cystic Fibrosis Foundation
Via Business Wire
Cystic Fibrosis Foundation Commits Up to $15.5M in Additional Funding for Potential Enzyme Therapy
From Cystic Fibrosis Foundation
Via Business Wire
Cystic Fibrosis Foundation Announces Kathryn Brown as Next Chief Communications and Marketing Officer
From Cystic Fibrosis Foundation
Via Business Wire
CF Foundation Invests Up to $15M in ReCode Therapeutics for Development of mRNA Therapy
From Cystic Fibrosis Foundation
Via Business Wire
Cystic Fibrosis Foundation Announces Irena Barisic as Next Chief Operating and Financial Officer
From Cystic Fibrosis Foundation
Via Business Wire
Cystic Fibrosis Foundation Invests $6M in Carbon Biosciences to Advance New Gene Therapy Approach for Cystic Fibrosis
From Cystic Fibrosis Foundation
Via Business Wire
Cystic Fibrosis Foundation Invests $5 Million in Sionna Therapeutics to Develop New CFTR Modulator Therapy
From Cystic Fibrosis Foundation
Via Business Wire
Cystic Fibrosis Foundation Launches Inaugural Golden Ticket Competition to Find the Next Genetic Therapies for CF
From Cystic Fibrosis Foundation
Via Business Wire
CF Foundation Funds Expansion of Clinical Trial Program for Potential Nonsense Mutations Therapy
From Cystic Fibrosis Foundation
Via Business Wire
Cystic Fibrosis Foundation Names KC White as Next Chair of Board of Trustees
From Cystic Fibrosis Foundation
Via Business Wire
Cystic Fibrosis Foundation Announces Steven Rowe, MD, as Next Chief Scientific Officer
From Cystic Fibrosis Foundation
Via Business Wire
Cystic Fibrosis Foundation Announces Investment in SalioGen Therapeutics to Fund Genetic Therapies Research
From Cystic Fibrosis Foundation
Via Business Wire
CF Foundation Awards Up to $5 Million to BiomX for Potential Phage Therapy
From Cystic Fibrosis Foundation
Via Business Wire
CF Foundation Invests $3.5 Million in Pulmocide for Development of Novel Antifungal Treatment for Lung Transplant Recipients
From Cystic Fibrosis Foundation
Via Business Wire
Cystic Fibrosis Foundation Strikes First-of-Its-Kind Deal With Pioneering Medicines, a Flagship Pioneering Initiative
From Cystic Fibrosis Foundation
Via Business Wire
CF Foundation Announces 2021 Impact Grant Recipients
From Cystic Fibrosis Foundation
Via Business Wire
The Cystic Fibrosis Foundation Affirms Support of the Introduction of the PASTEUR Act
From Cystic Fibrosis Foundation
Via Business Wire
First-of-Its-Kind Study Uses Smartphone to Track Cystic Fibrosis in Real Life
From Cystic Fibrosis Foundation
Via Business Wire
CF Foundation Funds Three New Research Awards to Advance its Path to a Cure Initiative
From Cystic Fibrosis Foundation
Via Business Wire
CF Foundation Invests Up to $8.4M in SpliSense for the Development of Potential Rare Mutation Therapy
From Cystic Fibrosis Foundation
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.